Merit Medical Systems, Inc. MMSI
87.41 USD -0.66 (-0.75%)
Nov 12, 2026, 10:54 AM EST
85.57 Day range 89.53
59.74 52-week range 94.85
- YTD
- -0.83%
- 1 year
- -0.81%
News
zacks.com Here's Why You Should Retain MMSI Stock in Your Portfolio for Now Merit Medical's strong product demand, innovation and acquisitions fuel growth, while tariffs, China market pressures and competition remain key challenges.
defenseworld.net Critical Review: Merit Medical Systems (NASDAQ:MMSI) and Olympus (OTCMKTS:OCPNY) Olympus (OTCMKTS:OCPNY - Get Free Report) and Merit Medical Systems (NASDAQ: MMSI - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two…
zacks.com HSIC vs. MMSI: Which Stock Should Value Investors Buy Now? Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Schein (HSIC) and Merit Medical (MMSI). But which of these two stocks presents investors with the…
globenewswire.com Merit Medical Presents Real-World Data from the AVF Cohort of the WRAP Global Registry SOUTH JORDAN, Utah, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced results from the AVF cohort of the WRAPSODY…
benzinga.com Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $121 Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $94 to $121.
benzinga.com JP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $110 JP Morgan analyst Robbie Marcus maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and raises the price target from $95 to $110.
benzinga.com Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $92 Wells Fargo analyst Larry Biegelsen maintains Merit Medical Systems (NASDAQ:MMSI) with a Equal-Weight and raises the price target from $83 to $92.
benzinga.com These Analysts Boost Their Forecasts On Merit Medical Systems After Strong Q3 Results Merit Medical beat Q3 estimates, raised FY2026 EPS guidance, narrowed sales outlook; analysts lifted price targets to $110 and $106.
benzinga.com Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $106 Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $101 to $106.
benzinga.com BTIG Maintains Buy on Merit Medical Systems, Raises Price Target to $110 BTIG analyst Sam Eiber maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $105 to $110.
benzinga.com Merit Medical Systems Q3 2026 Earnings Call Transcript Merit Medical Systems (NASDAQ:MMSI) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…- benzinga.com Merit Medical Systems Acquires Solo Pace For ~$45M Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced its acquisition of Solo Pace, Inc. (Solo Pace). Located in Minneapolis, Minnesota, Solo Pace…
benzinga.com Merit Medical Systems Raises FY2026 Adj EPS Guidance from $4.25-$4.35 to $4.33-$4.37 vs $4.30 Est; Narrows FY2026 Sales Guidance from $1.631B-$1.643B to $1.635B-$1.642B vs $1.636B Est Merit Medical Systems (NASDAQ:MMSI) raises FY2026 Adj EPS guidance from $4.25-$4.35 to $4.33-$4.37 vs $4.30 analyst estimate. Narrows FY2026 sales outlook from $1.631 billion-$1.643 billion to $1.635…- benzinga.com Merit Medical Systems Q3 Adj. EPS $1.12 Beats $1.03 Estimate, Sales $416.244M Beat $410.376M Estimate Merit Medical Systems (NASDAQ:MMSI) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $1.03 by 8.74 percent. This is a 21.74 percent increase over earnings…
- benzinga.com Freedom Capital Markets Initiates Coverage On Merit Medical Systems with Hold Rating, Announces Price Target of $90 Freedom Capital Markets analyst Keith Hinton initiates coverage on Merit Medical Systems (NASDAQ:MMSI) with a Hold rating and announces Price Target of $90.
benzinga.com Needham Reiterates Buy on Merit Medical Systems, Maintains $101 Price Target Needham analyst Mike Matson reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintains $101 price target.
benzinga.com Brinker International To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday Top analysts changed outlook on top names. Truist, Morgan Stanley, B of A Securities, HC Wainwright, Baird, and Stephens & Co. altered price targets for various stocks.
benzinga.com B of A Securities Maintains Neutral on Merit Medical Systems, Raises Price Target to $97 B of A Securities analyst Craig Bijou maintains Merit Medical Systems (NASDAQ:MMSI) with a Neutral and raises the price target from $92 to $97.- benzinga.com BTIG Reiterates Buy on Merit Medical Systems, Maintains $105 Price Target BTIG analyst Sam Eiber reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintains $105 price target.
- benzinga.com Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $94 Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $85 to $94.
benzinga.com JP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $95 JP Morgan analyst Robbie Marcus maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and raises the price target from $77 to $95.- benzinga.com Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $106 Piper Sandler analyst Jason Bednar maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and raises the price target from $96 to $106.
- benzinga.com Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $83 Wells Fargo analyst Larry Biegelsen maintains Merit Medical Systems (NASDAQ:MMSI) with a Equal-Weight and raises the price target from $74 to $83.
benzinga.com These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results Merit Medical Systems Inc (NASDAQ: MMSI) reported strong Q2 earnings, beating estimates with raised guidance. Analysts maintain Buy ratings with increased price targets.- benzinga.com Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $101 Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $90 to $101.
- benzinga.com BTIG Maintains Buy on Merit Medical Systems, Raises Price Target to $105 BTIG analyst Sam Eiber maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $100 to $105.
- benzinga.com Merit Medical Systems Raises FY2026 Adj EPS Guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 Est; Raises FY2026 Sales Guidance from $1.612B-$1.634B to $1.631B-$1.643B vs $1.620B Est Merit Medical Systems (NASDAQ:MMSI) raises FY2026 Adj EPS guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 analyst estimate. Raises FY2026 sales outlook from $1.612 billion-$1.634 billion to $1.631…
- benzinga.com Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $85 Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $90 to $85.
- benzinga.com JP Morgan Maintains Overweight on Merit Medical Systems, Lowers Price Target to $77 JP Morgan analyst Robbie Marcus maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and lowers the price target from $95 to $77.
- benzinga.com Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Lowers Price Target to $74 Wells Fargo analyst Larry Biegelsen maintains Merit Medical Systems (NASDAQ:MMSI) with a Equal-Weight and lowers the price target from $78 to $74.
- benzinga.com Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $90 Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $101 to $90.
benzinga.com Merit Medical Systems Q1 2026 Earnings Call Transcript 
benzinga.com Merit Medical Systems Affirms FY2026 Adj EPS Guidance of $4.01-$4.15 vs $4.03 Est; Raises FY2026 Sales Guidance from $1.610B-$1.630B to $1.612B-$1.634B vs $1.619B Est Merit Medical Systems (NASDAQ:MMSI) affirms FY2026 Adj EPS guidance from $4.01-$4.15 to $4.01-$4.15 vs $4.03 analyst estimate. Raises FY2026 sales outlook from $1.610 billion-$1.630 billion to $1.612…- benzinga.com Merit Medical Systems Q1 Adj. EPS $0.94 Beats $0.83 Estimate, Sales $381.877M Beat $377.632M Estimate Merit Medical Systems (NASDAQ:MMSI) reported quarterly earnings of $0.94 per share which beat the analyst consensus estimate of $0.83 by 13.25 percent. This is a 9.3 percent increase over earnings of…
benzinga.com Earnings Scheduled For April 30, 2026 - benzinga.com Barrington Research Maintains Outperform on Merit Medical Systems, Lowers Price Target to $107 Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and lowers the price target from $109 to $107.
- benzinga.com Piper Sandler Maintains Overweight on Merit Medical Systems, Lowers Price Target to $96 Piper Sandler analyst Jason Bednar maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and lowers the price target from $106 to $96.
benzinga.com FDA Warns Of Injury Risk Linked To Merit Medical Dialysis Kits The FDA labels Merit Medical catheter recall as high risk after injuries tied to a defective introducer used in dialysis kits.- benzinga.com FDA Says Aware That Merit Medical Issued Letter To Affected Customers Recommending Some Dialysis Catheters Be Removed From Where They Are Used/ Sold; As Of Feb 23, Merit Medical Has Reported Two Serious Injuries & No Deaths Associated With Some Certain Dialysis Catheters https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/dialysis-catheter-recall-merit-medical-removes-16f-dual-valved-splittable-sheath-introducer
- benzinga.com Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $90 Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $99 to $90.
- benzinga.com Merit Medical Systems Acquires View Point Medical For ~$140M Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is…
- benzinga.com Wells Fargo Downgrades Merit Medical Systems to Equal-Weight, Lowers Price Target to $78 Wells Fargo analyst Larry Biegelsen downgrades Merit Medical Systems (NASDAQ:MMSI) from Overweight to Equal-Weight and lowers the price target from $95 to $78.
- benzinga.com Barrington Research Maintains Outperform on Merit Medical Systems, Raises Price Target to $109 Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and raises the price target from $106 to $109.
benzinga.com 5 Analysts Have This To Say About Merit Medical Systems - benzinga.com Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $101 Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $108 to $101.
- benzinga.com Merit Medical Systems Sees FY2026 Adj EPS $4.01-$4.15 vs $4.04 Est; Sees Sales $1.610B-$1.630B vs $1.605B Est Merit Medical Systems (NASDAQ:MMSI) is looking for FY2026 Adj EPS of $4.01-$4.15 vs $4.04 analyst estimate. sees sales of $1.610 billion-$1.630 billion vs $1.605 billion analyst estimate.
- benzinga.com Merit Medical Systems Q4 Adj. EPS $1.04 Beats $0.95 Estimate, Sales $393.936M Beat $389.874M Estimate Merit Medical Systems (NASDAQ:MMSI) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.95 by 9.01 percent. This is a 11.83 percent increase over earnings…
- benzinga.com Earnings Scheduled For February 24, 2026
benzinga.com Carmax To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday - benzinga.com Piper Sandler Maintains Overweight on Merit Medical Systems, Lowers Price Target to $106 Piper Sandler analyst Jason Bednar maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and lowers the price target from $113 to $106.